Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 35 | $640,699 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 21 Feb 2025 18:07 | NKTR | NEKTAR THERAPEUTICS | ZALEVSKY JONATHAN | Chief R&D Officer | 19 Feb 2025 | Sale | 10,300 | 1.01 | 10,403 | D |
| 21 Feb 2025 18:06 | NKTR | NEKTAR THERAPEUTICS | WILSON MARK ANDREW | Chief Legal Officer | 19 Feb 2025 | Sale | 11,040 | 1.01 | 11,150 | D |
| 21 Feb 2025 18:04 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 19 Feb 2025 | Sale | 23,774 | 1.01 | 24,012 | D |
| 26 Dec 2024 19:04 | NKTR | NEKTAR THERAPEUTICS | WILSON MARK ANDREW | Chief Legal Officer | 23 Dec 2024 | Sale | 33,402 | 0.9 | 30,062 | D |
| 26 Dec 2024 19:04 | NKTR | NEKTAR THERAPEUTICS | WILSON MARK ANDREW | Chief Legal Officer | 24 Dec 2024 | Sale | 16,560 | 0.89 | 14,738 | D |
| 20 Dec 2024 20:33 | NKTR | NEKTAR THERAPEUTICS | ZALEVSKY JONATHAN | Chief R&D Officer | 19 Dec 2024 | Sale | 51,115 | 0.94 | 48,048 | D |
| 19 Dec 2024 21:08 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 17 Dec 2024 | Sale | 46,995 | 1.01 | 47,465 | D |
| 19 Dec 2024 21:08 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 18 Dec 2024 | Sale | 85,035 | 0.99 | 84,185 | D |
| 20 Nov 2024 20:37 | NKTR | NEKTAR THERAPEUTICS | ZALEVSKY JONATHAN | Chief R&D Officer | 19 Nov 2024 | Sale | 7,785 | 1.01 | 7,863 | D |
| 20 Nov 2024 20:36 | NKTR | NEKTAR THERAPEUTICS | WILSON MARK ANDREW | Chief Legal Officer | 19 Nov 2024 | Sale | 6,407 | 1.01 | 6,471 | D |
| 20 Nov 2024 20:36 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 19 Nov 2024 | Sale | 16,278 | 1.01 | 16,441 | D |
| 20 Aug 2024 21:15 | NKTR | NEKTAR THERAPEUTICS | ZALEVSKY JONATHAN | Chief R&D Officer | 19 Aug 2024 | Sale | 6,866 | 1.28 | 8,788 | D |
| 20 Aug 2024 21:15 | NKTR | NEKTAR THERAPEUTICS | WILSON MARK ANDREW | Chief Legal Officer | 19 Aug 2024 | Sale | 5,651 | 1.28 | 7,233 | D |
| 20 Aug 2024 21:14 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 19 Aug 2024 | Sale | 14,881 | 1.28 | 19,048 | D |
| 14 Jun 2024 18:02 | NKTR | NEKTAR THERAPEUTICS | CHESS ROBERT | Director | 14 Jun 2024 | Sale | 19,500 | 1.2 | 23,400 | D |
| 20 May 2024 21:14 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 17 May 2024 | Sale | 16,650 | 1.75 | 29,138 | D |
| 20 May 2024 21:13 | NKTR | NEKTAR THERAPEUTICS | ZALEVSKY JONATHAN | Chief R&D Officer | 17 May 2024 | Sale | 7,355 | 1.75 | 12,871 | D |
| 20 May 2024 21:12 | NKTR | NEKTAR THERAPEUTICS | WILSON MARK ANDREW | Chief Legal Officer | 17 May 2024 | Sale | 6,260 | 1.75 | 10,955 | D |
| 13 May 2024 16:36 | NKTR | NEKTAR THERAPEUTICS | DEEP TRACK CAPITAL, LP | 10% | 10 May 2024 | Sale | 56,000 | 1.7791 | 99,630 | I |
| 22 Feb 2024 20:19 | NKTR | NEKTAR THERAPEUTICS | ZALEVSKY JONATHAN | Chief R&D Officer | 20 Feb 2024 | Sale | 9,014 | 0.68 | 6,130 | D |
| 22 Feb 2024 20:17 | NKTR | NEKTAR THERAPEUTICS | WILSON MARK ANDREW | Chief Legal Officer | 20 Feb 2024 | Sale | 7,606 | 0.68 | 5,172 | D |
| 22 Feb 2024 20:16 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 20 Feb 2024 | Sale | 20,033 | 0.68 | 13,622 | D |
| 20 Nov 2023 21:02 | NKTR | NEKTAR THERAPEUTICS | ZALEVSKY JONATHAN | Chief R&D Officer | 17 Nov 2023 | Sale | 9,646 | 0.49 | 4,727 | D |
| 20 Nov 2023 21:00 | NKTR | NEKTAR THERAPEUTICS | WILSON MARK ANDREW | Chief Legal Officer | 17 Nov 2023 | Sale | 7,179 | 0.49 | 3,518 | D |
| 20 Nov 2023 20:58 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 17 Nov 2023 | Sale | 19,877 | 0.49 | 9,740 | D |
| 20 Sep 2023 20:09 | NKTR | NEKTAR THERAPEUTICS | CURET MYRIAM | Director | 18 Sep 2023 | Sale | 4,359 | 0.69 | 3,008 | D |
| 20 Sep 2023 20:08 | NKTR | NEKTAR THERAPEUTICS | CHESS ROBERT | Director | 22 Sep 2022 | Sale | 10,200 | 0.67 | 6,834 | D |
| 20 Sep 2023 20:06 | NKTR | NEKTAR THERAPEUTICS | AJER JEFFREY ROBERT | Director | 18 Sep 2023 | Sale | 4,359 | 0.69 | 3,008 | D |
| 17 Aug 2023 20:08 | NKTR | NEKTAR THERAPEUTICS | ZALEVSKY JONATHAN | Chief R&D Officer | 16 Aug 2023 | Sale | 9,703 | 0.78 | 7,568 | D |
| 17 Aug 2023 20:07 | NKTR | NEKTAR THERAPEUTICS | WILSON MARK ANDREW | Chief Legal Officer | 16 Aug 2023 | Sale | 7,221 | 0.78 | 5,632 | D |
| 17 Aug 2023 20:06 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 16 Aug 2023 | Sale | 19,998 | 0.78 | 15,598 | D |
| 15 Jun 2023 18:26 | NKTR | NEKTAR THERAPEUTICS | WHITFIELD ROY A | Director | 14 Jun 2023 | Sale | 30,000 | 0.57 | 17,100 | D |
| 17 May 2023 20:29 | NKTR | NEKTAR THERAPEUTICS | ZALEVSKY JONATHAN | Chief R&D Officer | 16 May 2023 | Sale | 9,791 | 0.72 | 7,050 | D |
| 17 May 2023 20:28 | NKTR | NEKTAR THERAPEUTICS | WILSON MARK ANDREW | Chief Legal Officer | 16 May 2023 | Sale | 7,543 | 0.72 | 5,431 | D |
| 17 May 2023 20:27 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | President & CEO | 16 May 2023 | Sale | 20,361 | 0.72 | 14,660 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)